117 related articles for article (PubMed ID: 9112450)
1. A feasibility study of accelerated fractionation in radiotherapy of carcinoma of the urinary bladder.
Moonen L; van der Voet H; Horenblas S; Bartelink H
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):537-42. PubMed ID: 9112450
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the effect of reducing the high-dose volume on the toxicity of radiotherapy in the treatment of bladder cancer.
Mangar SA; Foo K; Norman A; Khoo V; Shahidi M; Dearnaley DP; Horwich A; Huddart RA
Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):466-73. PubMed ID: 16909970
[TBL] [Abstract][Full Text] [Related]
3. Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer.
Yavuz AA; Yavuz MN; Ozgur GK; Colak F; Ozyavuz R; Cimsitoglu E; Ilis E
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):734-45. PubMed ID: 12788179
[TBL] [Abstract][Full Text] [Related]
4. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
5. A feasibility study of partially accelerated radiotherapy for invasive bladder cancer.
Plataniotis G; Michalopoulos E; Kouvaris J; Vlahos L; Papavasiliou C
Radiother Oncol; 1994 Oct; 33(1):84-7. PubMed ID: 7878215
[TBL] [Abstract][Full Text] [Related]
6. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
Horwich A; Dearnaley D; Huddart R; Graham J; Bessell E; Mason M; Bliss J
Radiother Oncol; 2005 Apr; 75(1):34-43. PubMed ID: 15878099
[TBL] [Abstract][Full Text] [Related]
7. Factors determining acute normal tissue reactions during postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases.
Jereczek-Fossa BA; Badzio A; Jassem J
Radiother Oncol; 2003 Jul; 68(1):33-9. PubMed ID: 12885450
[TBL] [Abstract][Full Text] [Related]
8. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
[TBL] [Abstract][Full Text] [Related]
9. Late complications after postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases with application of linear-quadratic model.
Jereczek-Fossa B; Jassem J; Nowak R; Badzio A
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):329-38. PubMed ID: 9607348
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study.
Murthy V; Masodkar R; Kalyani N; Mahantshetty U; Bakshi G; Prakash G; Joshi A; Prabhash K; Ghonge S; Shrivastava S
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):60-66. PubMed ID: 26547385
[TBL] [Abstract][Full Text] [Related]
11. Once weekly irradiation for carcinoma of the bladder.
Rostom AY; Tahir S; Gershuny AR; Kandil A; Folkes A; White WF
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):289-92. PubMed ID: 8635935
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment.
Hafeez S; McDonald F; Lalondrelle S; McNair H; Warren-Oseni K; Jones K; Harris V; Taylor H; Khoo V; Thomas K; Hansen V; Dearnaley D; Horwich A; Huddart R
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):115-122. PubMed ID: 28586948
[TBL] [Abstract][Full Text] [Related]
13. Acute and late toxicity in radical radiotherapy for bladder cancer.
Majewski W; Tarnawski R
Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):598-609. PubMed ID: 19632819
[TBL] [Abstract][Full Text] [Related]
14. Concomitant boost radiotherapy for muscle invasive bladder cancer.
Pos FJ; van Tienhoven G; Hulshof MC; Koedooder K; González González D
Radiother Oncol; 2003 Jul; 68(1):75-80. PubMed ID: 12885455
[TBL] [Abstract][Full Text] [Related]
15. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
[TBL] [Abstract][Full Text] [Related]
16. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
[TBL] [Abstract][Full Text] [Related]
17. Results of a randomised study to evaluate influence of dose on morbidity in radiotherapy for bladder cancer.
Quilty PM; Duncan W; Kerr GR
Clin Radiol; 1985 Nov; 36(6):615-8. PubMed ID: 4064546
[TBL] [Abstract][Full Text] [Related]
18. Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.
McCammon R; Rusthoven KE; Kavanagh B; Newell S; Newman F; Raben D
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):413-20. PubMed ID: 19362783
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of accelerated fractionation in the radiotherapy of invasive carcinoma of the bladder.
Cole DJ; Durrant KR; Roberts JT; Dawes PJ; Yosef H; Hopewell JW
Br J Radiol; 1992 Sep; 65(777):792-8. PubMed ID: 1393417
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated radiotherapy for patients with carcinoma of the bladder.
Jose CC; Price A; Norman A; Jay G; Huddart R; Dearnaley DP; Horwich A
Clin Oncol (R Coll Radiol); 1999; 11(5):330-3. PubMed ID: 10591821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
